Hydromed (Hydrochlorothiazide)

Hydrochlorothiazide acts on the distal convoluted tubule of the kidney by blocking the sodium‑chloride symporter. This inhibition reduces reabsorption of sodium and chloride, leading to increased urinary excretion of these ions together with water. The resulting decrease in extracellular fluid volume lowers cardiac output and systemic vascular resistance, helping to control blood pressure and edema.

The appropriate dose of Hydromed is individualized by the prescribing clinician based on the patient’s medical condition, response to therapy, renal function, and electrolyte status. Dosage may be started low and adjusted as needed, but exact strength and frequency should only be set by a qualified healthcare professional.

Safety data for hydrochlorothiazide in pregnancy are limited, and the drug is generally used only if the potential benefit outweighs the risk to the fetus. It is excreted in breast milk, so caution is advised for nursing mothers. Physicians should evaluate each case carefully and discuss possible alternatives.

To request Hydromed, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifying trade or institutional credentials before providing a formal quotation that includes pricing, availability, shipping terms, and any necessary import documentation.

Hydromed (hydrochlorothiazide) belongs to the thiazide diuretic class, which lowers blood pressure primarily by reducing fluid volume. Compared with ACE inhibitors or calcium‑channel blockers, thiazides are often less expensive and can be combined with other agents for additive effect. However, they may cause electrolyte disturbances that are less common with some alternative classes.

Hydromed should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments to maintain tablet integrity.

Hydromed is taken orally, usually as a tablet swallowed whole with a full glass of water. It can be taken with or without food, but patients should follow the prescribing clinician’s instructions regarding timing and any specific dietary considerations.

The most critical risks include severe electrolyte imbalances such as hypokalemia or hyponatremia, which can lead to cardiac arrhythmias, and acute kidney injury, especially in patients with pre‑existing renal impairment. Rare but serious reactions may involve anaphylaxis, pancreatitis, or profound dehydration requiring immediate medical attention.

Hydromed is contraindicated in patients with known hypersensitivity to hydrochlorothiazide or other sulfonamide-derived drugs. It should also be avoided in individuals with anuria, severe renal or hepatic impairment, and in those with significant electrolyte disturbances that have not been corrected. Clinicians must assess each patient’s medical history before prescribing.